Non-ownership Filings
| GSK completes acquisition of efimosfermin for SLD | Jul. 07, 2025 |
| Total Voting Rights | Jul. 01, 2025 |
| Director Declaration | Jun. 24, 2025 |
| Replacement RNS: Linerixibat file accepted by EMA | Jun. 23, 2025 |
| GSK Submits Arexvy for adults 18+ with EMA | Jun. 23, 2025 |
| Arexvy filed in Japan for 18-49 at increased risk | Jun. 20, 2025 |
| GSK submits Arexvy for adults 18+ with EMA | Jun. 13, 2025 |
Ownership Update Filings
| Transaction in Own Shares | Jul. 11, 2025 |
| Transaction in Own Shares | Jul. 10, 2025 |
| Transaction in Own Shares | Jul. 09, 2025 |
| Transaction in Own Shares | Jul. 08, 2025 |
| Transaction in Own Shares | Jul. 07, 2025 |
| Transaction in Own Shares | Jul. 04, 2025 |
| Transaction in Own Shares | Jul. 03, 2025 |